Dicoumarol sensitizes renal cell carcinoma Caki cells to TRAIL-induced apoptosis through down-regulation of Bcl-2, Mcl-1 and c-FLIP in a NQO1-independent manner

Exp Cell Res. 2014 Apr 15;323(1):144-154. doi: 10.1016/j.yexcr.2014.01.009. Epub 2014 Jan 22.

Abstract

In the study, we investigated the effect of dicoumarol, an anti-coagulant agent with the inhibitory activity of NAD(P)H quinone oxidoreductase 1 (NQO1), on TRAIL-induced apoptosis in renal cancer cell. Combined treatment with dicoumarol and TRAIL significantly induced apoptosis in various human renal carcinoma cells including Caki, ACHN, and A498, but not in normal human skin fibroblasts (HSF) and mouse kidney cells (TMCK-1). When we elucidated the relevance of NQO1 in dicoumarol plus TRAIL-mediated apoptosis, both ES936 (a NQO1 inhibitor) and knockdown of NQO1 with siRNA had no effect on TRAIL-mediated apoptosis, suggesting that the stimulating effect of dicoumarol on TRAIL-mediated apoptosis is independent of NQO1 activity. We found that dicoumarol transcriptionally down-regulated Bcl-2 expression via inhibition of NF-κB and CREB activity, whereas it down-regulated Mcl-1 and c-FLIP expression at the post-translational level. Overexpression of Bcl-2, Mcl-1, or c-FLIP overcame the dicoumarol plus TRAIL-induced apoptosis, indicating that down-regualtion of these anti-apoptotic proteins may critically contribute to the sensitizing effect of dicoumarol on TRAIL-mediated apoptosis.

Keywords: Bcl-2; Dicoumarol; Mcl-1; NQO1; TRAIL; c-FLIP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • CASP8 and FADD-Like Apoptosis Regulating Protein / biosynthesis
  • CASP8 and FADD-Like Apoptosis Regulating Protein / metabolism
  • CREB-Binding Protein / antagonists & inhibitors
  • Carcinoma, Renal Cell / metabolism*
  • Cell Line, Tumor
  • Dicumarol / pharmacology*
  • Down-Regulation
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Indolequinones / pharmacology
  • Kidney Neoplasms / metabolism*
  • Mice
  • Myeloid Cell Leukemia Sequence 1 Protein / biosynthesis
  • Myeloid Cell Leukemia Sequence 1 Protein / metabolism
  • NAD(P)H Dehydrogenase (Quinone) / antagonists & inhibitors
  • NAD(P)H Dehydrogenase (Quinone) / genetics
  • NAD(P)H Dehydrogenase (Quinone) / metabolism
  • NF-kappa B / antagonists & inhibitors
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • RNA Interference
  • RNA, Small Interfering
  • Reactive Oxygen Species / metabolism
  • Signal Transduction / drug effects
  • TNF-Related Apoptosis-Inducing Ligand / metabolism*
  • Transcription Factor CHOP / genetics
  • Transcription, Genetic / drug effects

Substances

  • 5-methoxy-1,2-dimethyl-3-((4-nitrophenoxy)methyl)indole-4,7-dione
  • CASP8 and FADD-Like Apoptosis Regulating Protein
  • CFLAR protein, human
  • DDIT3 protein, human
  • Enzyme Inhibitors
  • Indolequinones
  • MCL1 protein, human
  • Myeloid Cell Leukemia Sequence 1 Protein
  • NF-kappa B
  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Small Interfering
  • Reactive Oxygen Species
  • TNF-Related Apoptosis-Inducing Ligand
  • TNFSF10 protein, human
  • Transcription Factor CHOP
  • Dicumarol
  • NAD(P)H Dehydrogenase (Quinone)
  • NQO1 protein, human
  • CREB-Binding Protein
  • CREBBP protein, human